Naloxone-induced cortisol predicts mu opioid receptor binding potential in specific brain regions of healthy subjects

Psychoneuroendocrinology

Volumn 36, Issue 10, 2011, Pages 1453-1459

  Wand, Gary S ^a   Weerts, Elise M ^a   Kuwabara, Hiroto ^a   Frost, J James ^a   Xu, Xiaoqiang ^a   McCaul, Mary E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Beta endorphin; Cortisol; HPA axis; Mu Opioid receptors; Naloxone; PET imaging

Indexed keywords

CARFENTANIL C 11; CORTICOTROPIN; HYDROCORTISONE; MU OPIATE RECEPTOR; NALOXONE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BINDING KINETICS; BRAIN FUNCTION; CAUDATE NUCLEUS; CORPUS STRIATUM; DOSE RESPONSE; DRUG MECHANISM; FEMALE; HIPPOCAMPUS; HORMONE RESPONSE; HUMAN; HUMAN EXPERIMENT; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; RECEPTOR BINDING; SEX; SMOKING;

ADULT; BRAIN; FEMALE; FORECASTING; HEALTH; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; NALOXONE; NARCOTIC ANTAGONISTS; ORGAN SPECIFICITY; PITUITARY-ADRENAL SYSTEM; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; RECEPTORS, OPIOID, MU; UP-REGULATION;

EID: 80054859839     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2011.03.019     Document Type: Article

References (42)

1. Adinoff B., Krebaum S.R., Chandler P.A., Ye W., Brown M.B., Williams M.J. Dissection of hypothalamic-pituitary-adrenal pathology in one-month abstinent alcohol-dependent men: response to CRH and naloxone. Alcohol. Clin. Exp. Res. 2005, 29:528-537.
2. Alexander S.L., Irvine C.H. The effect of naloxone administration on the secretion of corticotrophin-releasing hormone, arginine vasopressin, and adrenocorticotropin in unperturbed horses. Endocrinology 1995, 136(11):5139-5147.
3. Barson J.R., Carr A.J., Soun J.E., Sobhani N.C., Rada P., Leibowitz S.F., Hoebel B.G. Opioids in the hypothalamic paraventricular nucleus stimulate ethanol intake. Alcohol. Clin. Exp. Res. 2010, 34(2):214-222.
4. Bencherif B., Wand G.S., McCaul M.E., Kim Y.K., Ilgin N., Dannals R.F., Frost J.J. Mu-opoid receptor binding measured by [11C]carfentanil positron emission tomography is related to craving and mood in alcohol dependence. Biol. Psychiatry 2004, 55:255-262.
5. Bencherif B., Fuchs P.N., Sheth R., Dannals R.F., Campbell J.N., Frost J.J. Pain activation of human supraspinal opioid pathways as demonstrated by [11C]-carfentanil and positron emission tomography (PET). Pain 2002, 99(3):589-598.
6. Berridge K.C., Ho C.Y., Richard J.M., Difeliceantonio A.G. The tempted brain eats: pleasure and desire circuits in obesity and eating disorders. Brain Res. 2010, Epub ahead of print.
7. Bucholz K.K., Cadoret R., Cloninger C.R., Dinwiddie S.H., Hesselbrock V.M., Nurnberger J.I., Reich T., Schmidt I., Schuckit MA A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA. J. Stud. Alcohol 1994, 55:149-158.
8. Endres C.J., Bencherif B., Hilton J., Madar I., Frost J.J. Quantification of brain mu-opioid receptors with [11C]carfentanil: reference-tissue methods. Nucl. Med. Biol. 2003, 30:177-186.
9. Frost J.J., Mayberg H.S., Sadzot B., Dannals R.F., Lever J.R., Ravert H.T., Wilson A.A., Wagner H.N., Links J.M. Comparison of [11C]diprenorphine and [11C]carfentanil binding to opiate receptors in humans by positron emission tomography. J. Cereb. Blood Flow Metab. 1990, 10:484-492.
10. Gorelick D.A., Kim Y.K., Bencherif B., Boyd S.J., Nelson R., Copersino M.L., Dannals R.F., Frost J.J. Brain mu-opioid receptor binding: relationship to relapse to cocaine use after monitored abstinence. Psychopharmacology (Berl.) 2008, 200(4):475-486.
11. Hammers A., Allom R., Koepp M.J., Free S.L., Myers R., Lemieux L., Mitchell T.N., Brooks D.J., Duncan J.S. Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum. Brain Mapp. 2003, 19:224-247.
12. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerström K.O. The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br. J. Addict. 1991, 86(9):1119-1127.
13. Heinz A., Reimold M., Wrase J., Hermann D., Croissant B., Mundle G., Dohmen B.M., Braus D.F., Schumann G., Machulla H.J., Bares R., Mann K. Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil. Arch. Gen. Psychiatry 2005, 62(1):57-64.
14. Herman J.P., Ostrander M.M., Mueller N.K., Figueiredo H. Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29(8):1201-1213.
15. Hochberg Y., Benjamini Y. More powerful procedures for multiple significance testing. Stat. Med. 1990, 9:811-818.
16. Innis R.B., Cunningham V.J., Delforge J., Fujita M., Gjedde A., Gunn R.N., Holden J., Houle S., Huang S.C., Ichise M., Iida H., Ito H., Kimura Y., Koeppe R.A., Knudsen G.M., Knuuti J., Lammertsma A.A., Laruelle M., Logan J., Maguire R.P., Mintun M.A., Morris E.D., Parsey R., Price J.C., Slifstein M., Sossi V., Suhara T., Votaw J.R., Wong D.F., Carson RE Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J. Cereb. Blood Flow Metab. 2007, 27:1533-1539.
17. Kinahan P.E., Rogers J.G. Analytic 3D image reconstruction using all detected events. Nucl. Sci. IEEE Trans. 1989, 36:964-968.
18. Lever J.R. In vivo binding of N1'-([11C]naltrindole to delta-opioid receptors in mouse brain. Eur. J. Pharmacol. 1992, 216:459-460.
19. Logan J., Fowler J.S., Volkow N.D., Wang G.J., Ding Y.S., Alexoff D.L. Distribution volume ratios without blood sampling from graphical analysis of PET data. J. Cereb. Blood Flow Metab. 1996, 16:834-840.
20. Madar I. Imaging of delta opioid receptors in human brain by N1'-([11C]methyl)naltrindole and PET. Synapse 1996, 24:19-28.
21. Mangold D., Wand G. Cortisol and ACTH responses to naloxone in subjects with high and low neuroticism. Biol. Psychiatry 2006, 60:850-855.
22. Mangold D., McCaul M., Ali M., Wand G.S. Generating a dose response curve to naloxone in a single session. Biol. Psychiatry 2000, 48:310-314.
23. Marinelli M., Piazza P.V. Interaction between glucocorticoid hormones, stress and psychostimulant drugs. Eur. J. Neurosci. 2002, 16(3):387-394.
24. Mazziotta J.C., Toga A.W., Evans A., Fox P., Lancaster J. A probabilistic atlas of the human brain: theory and rationale for its development. The international Consortium for Brain Mapping (ICBM). Neuroimage 1995, 2:89-101.
25. Meltzer C.C., Bryan R.N., Holcomb H.H., Kimball A.W., Mayberg H.S., Sadzot B., Leal J.P., Wagner H.N., Frost J.J. Anatomical localization for PET using MR imaging. J. Comput. Assist. Tomogr. 1990, 14:418-426.
26. Oswald L., Wand G. Opioids and alcohol. Physiol. Behav. 2004, 81(2):339-358.
27. Oswald L.M., Mathena J.R., Wand G.S. Comparison of HPA axis hormonal responses to naloxone vs psychologically-induced stress. Psychoneuroendocrinology 2004, 29(3):371-388.
28. Oswald L.M., Wong D.F., McCaul M., Zhou Y., Kuwabara H., Choi L., Brasic J., Wand GS Relationships among ventral striatal dopamine release, cortisol secretion, and subjective responses to amphetamine. Neuropsychopharmacy 2005, 30:821-832.
29. Russell J.A., Douglas A.J., Brunton P.J. Reduced hypothalamo-pituitary-adrenal axis stress responses in late pregnancy: central opioid inhibition and noradrenergic mechanisms. Ann. N. Y. Acad. Sci. 2008, 1148:428-438.
30. Solati J., Zarrindast M.R., Salari A.A. Dorsal hippocampal opioidergic system modulates anxiety-like behaviors in adult male Wistar rats. Psychiatry Clin. Neurosci. 2010 Oct 28, Epub ahead of print. 10.1111/j.1440-1819.2010.02143.x.
31. Torpy D.J., Grice J.E., Hockings G.I., Walters M.M., Crosbie G.V., Jackson R.V. Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man. J. Clin. Endocrinol. Metab. 1993, 76(2):388-391.
32. Uhart M., Chong R., Oswald L., Ping L., Wand G.S. Gender differences in hypothalamic-pituitary-adrenal (HPa) axis reactivity. Psychoneuroendocrinology 2006, 31(5):642-652.
33. Wand G.S. The influence of stress on the transition from drug use to addiction. Natl. Inst. Health Alcohol Health Res. 2008, 31(2):119-136.
34. Wand G.S., Oswald L.M., McCaul M.E., Wong D.F., Johnson E., Zhou Y., Kuwabara H., Kumar A. Association of amphetamine-induced striatal dopamine release and cortisol responses to psychological stress. Neuropsychopharmacology 2007, 32(11):2310-2320.
35. Wand G.S., Mangold D., Ali M. Adrenocorticotropin response to naloxone in sons of alcohol dependent men. J. Clin. Endocrinol. Metab. 1999, 84:64-68.
36. Wand G.S., Mangold D., El Diery S., McCaul M., Hoover D. Family history of alcoholism and hypothalamic opioidergic activity. Arch. Gen. Psychiatry 1998, 55:1114-1119.
37. Wand G.S., McCaul M., Gotjen D., Reynolds J., Lee S. Confirmation that offspring from families with alcohol dependent individuals have greater HPA axis activation-induced by naloxone compared to offspring without a family history of alcohol dependence. Alcohol. Clin. Exp. Res. 2001, 25:1134-1139.
38. Wand G.S., McCaul M., Gotjen D., Reynolds J., Lee S. The mu opioid receptor gene polymorphism A(118)G alters HPA axis activation induced by opioid receptor blockade. Neuropsychopharmacology 2002, 26:106-114.
39. Williams T.M., Davies S.J., Taylor L.G., Daglish M.R., Hammers A., Brooks D.J., Nutt D.J., Lingford-Hughes A. A Brain opioid receptor binding in early abstinence from alcohol dependence and relationship to craving: an [11C]diprenorphine PET study. Eur. Neuropsychopharmacol. 2009, 19:740-748.
40. Wise R.A. Dopamine and reward: the anhedonia hypothesis 30 years on. Neurotox. Res. 2008, 14(2-3):169-183.
41. Zarrindast M.R., Babapoor-Farrokhran S., Babapoor-Farrokhran S., Rezayof A. Involvement of opioidergic system of the ventral hippocampus, the nucleus accumbens or the central amygdala in anxiety-related behavior. Life Sci. 2008 Jun 6, 82(23-24):1175-1181.
42. Zubieta J.K., Dannals R.F., Frost J.J. Gender and age influences on human brain mu-opioid receptor binding measured by PET. Am. J. Psychiatry 1999, 156(6):842-848.